IL48734A - Process for removing endotoxin from biological fluids - Google Patents

Process for removing endotoxin from biological fluids

Info

Publication number
IL48734A
IL48734A IL48734A IL4873475A IL48734A IL 48734 A IL48734 A IL 48734A IL 48734 A IL48734 A IL 48734A IL 4873475 A IL4873475 A IL 4873475A IL 48734 A IL48734 A IL 48734A
Authority
IL
Israel
Prior art keywords
biological fluids
removing endotoxin
endotoxin
fluids
biological
Prior art date
Application number
IL48734A
Other languages
English (en)
Other versions
IL48734A0 (en
Original Assignee
Preventive Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Preventive Systems filed Critical Preventive Systems
Publication of IL48734A0 publication Critical patent/IL48734A0/xx
Publication of IL48734A publication Critical patent/IL48734A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/03—Heart-lung

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
IL48734A 1974-12-27 1975-12-25 Process for removing endotoxin from biological fluids IL48734A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/536,833 US3959128A (en) 1974-12-27 1974-12-27 Process for removing endotoxin from biological fluids

Publications (2)

Publication Number Publication Date
IL48734A0 IL48734A0 (en) 1976-04-30
IL48734A true IL48734A (en) 1978-07-31

Family

ID=24140112

Family Applications (1)

Application Number Title Priority Date Filing Date
IL48734A IL48734A (en) 1974-12-27 1975-12-25 Process for removing endotoxin from biological fluids

Country Status (3)

Country Link
US (1) US3959128A (fr)
CA (1) CA1056727A (fr)
IL (1) IL48734A (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4059512A (en) * 1974-12-27 1977-11-22 Preventive Systems, Inc. Process for removing endotoxin from biological fluids
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
US4116826A (en) * 1975-11-28 1978-09-26 International Telephone And Telegraph Corp. Water purification methods
US4411795A (en) * 1980-03-10 1983-10-25 Baxter Travenol Laboratories, Inc. Particle adsorption
US4273557A (en) * 1980-03-31 1981-06-16 Mallinckrodt, Inc. Limulus lysate procedure for determining endotoxins
US4464165A (en) * 1980-11-24 1984-08-07 American Hoechst Corporation Material and method for removing immunoglobulins from whole blood
US4381004A (en) * 1981-01-15 1983-04-26 Biomedics, Inc. Extracorporeal system for treatment of infectious and parasitic diseases
US4381239A (en) * 1981-02-10 1983-04-26 Tanabe Seiyaku Co., Ltd. Method for reducing the pyrogen content of or removing pyrogens from substances contaminated therewith
US4488969A (en) * 1982-02-09 1984-12-18 Amf Incorporated Fibrous media containing millimicron-sized particulates
US4685900A (en) * 1983-06-01 1987-08-11 Biospecific Technologies, Inc. Therapeutic device
JPH0738880B2 (ja) * 1983-06-24 1995-05-01 東レ株式会社 エンドトキシン血症治療剤
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
US5084558A (en) * 1987-10-13 1992-01-28 Biopure Corporation Extra pure semi-synthetic blood substitute
CA1312009C (fr) * 1986-11-10 1992-12-29 Carl W. Rausch Substitut sanguin semi-synthetique extra pur
US5753616A (en) * 1986-11-10 1998-05-19 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5955581A (en) * 1986-11-10 1999-09-21 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5733254A (en) * 1987-10-15 1998-03-31 Cypress Bioscience, Inc. Method for treating patients suffering from immune thrombocytopenic purpura
US5182317A (en) * 1988-06-08 1993-01-26 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coatings and methods of manufacture
US5262451A (en) * 1988-06-08 1993-11-16 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coatings and methods of manufacture
US5342693A (en) * 1988-06-08 1994-08-30 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coating and methods of manufacture
US5187066A (en) * 1990-02-14 1993-02-16 Syntex (U.S.A.) Inc. Methods for detecting amphiphilic antigens
WO1991017724A1 (fr) * 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Polymere utilise dans un dispositif medical
ES2104855T3 (es) * 1991-12-24 1997-10-16 Wako Pure Chem Ind Ltd Procedimiento para extraer endotoxinas.
AU2198592A (en) * 1992-02-20 1993-09-13 Alliance Pharmaceutical Corporation Inhibition of bacterial endotoxin
DE4331358A1 (de) * 1992-10-12 1994-04-14 Braun Melsungen Ag Verfahren zur quantitativen selektiven Entfernung oder präparativen Gewinnung von Tumor-Nekrose-Faktor (TNF) oder/und Lipopolysacchariden (LPS) aus wäßrigen Flüssigkeiten
US5578455A (en) * 1993-03-19 1996-11-26 Tanabe Seiyaku Co., Ltd. Method for determining endotoxin and apparatus therefor
AUPM388494A0 (en) * 1994-02-16 1994-03-10 Csl Limited Process for removing endotoxins
US6150507A (en) * 1995-03-23 2000-11-21 Biopure Corporation Method for producing a purified hemoglobin product
DE19515554C2 (de) * 1995-04-27 1999-06-17 Braun Melsungen Ag Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
US6186146B1 (en) 1996-08-30 2001-02-13 Delcath Systems Inc Cancer treatment method
US6106723A (en) * 1997-02-10 2000-08-22 Grandics; Peter Method for removing pyrogens from dialysate
US5817046A (en) * 1997-07-14 1998-10-06 Delcath Systems, Inc. Apparatus and method for isolated pelvic perfusion
US5919163A (en) * 1997-07-14 1999-07-06 Delcath Systems, Inc. Catheter with slidable balloon
US6745903B2 (en) * 2002-03-14 2004-06-08 Peter Grandics Methods for the on-line, on-demand preparation of sterile, water-for-injection grade water
US20110295175A1 (en) * 2010-03-16 2011-12-01 Marv Enterprises Llc Sequential Extracoporeal Treatment of Bodily Fluids
US11918728B2 (en) 2014-04-17 2024-03-05 ImMutriX Therapeutics, Inc. Therapeutic compositions for viral-associated disease states and methods of making and using same
US9669151B2 (en) 2014-04-17 2017-06-06 ImMutriX Therapeutics, Inc. Therapeutic compositions for viral-associated disease states and methods of making and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794584A (en) * 1970-04-09 1974-02-26 Rohm & Haas Removal of poisons and drugs from blood
US3770631A (en) * 1971-06-29 1973-11-06 Baxter Laboratories Inc Clarification of blood serum and plasma

Also Published As

Publication number Publication date
CA1056727A (fr) 1979-06-19
US3959128A (en) 1976-05-25
IL48734A0 (en) 1976-04-30

Similar Documents

Publication Publication Date Title
IL48734A (en) Process for removing endotoxin from biological fluids
AU497305B2 (en) Filtering process & apparatus
ZA753023B (en) Purification process
YU40117B (en) Process for obtaining n-phosphonomethyglycine
ZA752537B (en) Speciment treatment apparatus
IL44239A0 (en) Process and apparatus for cleaning used oils
YU39534B (en) Process for obtaining n-phosphono-methyl-glycine
YU36910B (en) Process for obtaining tertiary olefines
AU8409375A (en) Process optimisation
HU178514B (en) Process for refining water
HK24482A (en) Process for cleaning aluminium
IL47646A0 (en) Fluid fractionating membrane apparatus
BE823623A (nl) Werkwijze ter bereiding van micro-organismen
YU294281A (en) Process for obtaining 7-hydroxyestradiols
AU8373875A (en) Filtration apparatus
ZA753674B (en) A process for removing dissolved substances from liquids
IL44529A0 (en) Separation process
ZA756281B (en) Filtration process
ZM3175A1 (en) Chemical process
ZA752869B (en) Process for clarifying liquids
CS194770B2 (en) Process for removing acetylenic compouns
AU7942075A (en) Apparatus for liquid extraction
IL43057A0 (en) Process and apparatus for removing ions from fluids
YU247075A (en) Process for obtaining 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercapto-methyl-pyridine
YU234275A (en) Process for obtaining 6-chloro-6-chloromethyl-4-phenyl-quinazoline-3-oxide